Joanne Weidhaas

Joanne is a co-founder of MiraDx and Professor at the David Geffen School of Medicine at UCLA and head of translation research, in the Department of Therapeutic Radiology. Her pioneering research led to the co-discovery of the KRAS-variant, a strong predictor of cancer risk, tumor biology, and treatment response. Her passion for empowering individuals to take charge of their health led her to found MiraDx, a genomics company dedicated to giving people and their doctor's actionable information to better treat cancer. Joanne completed her oncology training at Memorial Sloan-Kettering Cancer Center in New York City and previously served as the Chief of the Breast Cancer Radiation Service at Yale Cancer Center and the Section Chief, of Breast Cancer, at Yale Cancer Center. She took a sabbatical while at Yale and completed an MBM at Stanford University. She has recently moved to UCLA as Division Head, Translational Research. Her dual role as a clinician and researcher enables her to apply genetic breakthroughs to the benefit of her patients.